Boston Biotech Clinical Research
  • Home
    • SCIO Path to Approval
  • Early Clinical Research
    • Strategy and TPP
    • Translational Medicine and Epigenetics
    • Biologics, Cell and Gene Therapy
    • Real World Evidence
    • Repurposing
  • Orphan Drug Solutions
    • Biomarkers and Surrogate Endpoints
    • Regulatory Affairs FDA and EMA
    • Medical Affairs and Clinical Research
    • Due Diligence
    • Trial Management & Trial Rescue
  • People
    • Senior Advisors
      • Candida Fratazzi
      • Claudio Carini
      • Federico Goodsaid
    • Our Clients
    • Our Collaborators
    • Testimonials
  • Resources
    • BBCR Voice
    • Case Studies
    • Published Studies
    • Conferences & Presentations
    • Job Opportunities
    • Contact Info
Select Page

Real World Evidence

BBCR Company News

Inventor of the PCR, Kary Mullis, Dies

August 15th, 2019 | Real World Evidence

Longer Stretch To The Finish Line for CNS Diseases

August 7th, 2019 | Real World Evidence

Cost vs. Value: Can We Have Both?

August 1st, 2019 | Real World Evidence

Could Seamless Adaptive Designs Advance Rare Disease Clinical Trial Design?

July 24th, 2019 | Real World Evidence

Gene Therapy for Rare Disorders Europe 2019 – October 15th – 17th, London

July 15th, 2019 | Real World Evidence

BBCR is Hiring! Boston Biotech Clinical Research is looking for a Full Time Associate Clinical Scientist to join our team!

June 21st, 2019 | Real World Evidence

SCIO Helps Early Stage Biotech Company Evaluation

January 24th, 2019 | Real World Evidence

A success story by BBCR Consulting: Candida Fratazzi MD was CMO at Ichorion Therapeutics in 2018

December 17th, 2018 | Real World Evidence

Welcome to BBCR’s New Website!

December 7th, 2018 | Real World Evidence
Newer posts »

Categories

  • Biomarkers & Surrogate Endpoints
  • Company News
  • Drug Development
  • Due Diligence
  • Early Clinical Development
  • Industry News
  • Medical Affairs and Clinical Research
  • Miscellaneous
  • Orphan Diseases
  • Pre-IND
  • Precision Medicine
  • Rare Disease
  • Real World Evidence
  • Regulatory
  • Regulatory Affairs
  • Strategy and TPP
  • Translation Medicine and Epigenetics
  • Trial Management
  • Trial Rescue

Recent Posts

  • BBCR’s team of experts help clients match treatments to rare genetic conditions and unsolved diseases, then work collaboratively with a product developer on the best plan to market. To learn more, visit bbcrconsulting.com.
  • Drug repurposing accelerates the path from discovery to the clinic, offering particular promise for rare, neglected, oncologic, and neurodegenerative diseases. Learn how we can help at bbcrconsulting.com
  • Is Your Drug Development Strategy Built for Tomorrow’s Success?
  • BBCR assists companies with the identification and adoption of biomarkers, now a routine part of drug development, and especially valuable in rare disease and precision medicine product development. Reach out to us to learn how we can assist with your development project.
  • Partnering with BBCR Consulting means gaining the support of a specialized team committed to making the clinical trial process more efficient.

RSS Nasdaq Globe Newswire

  • BBOT to Present at the 44th Annual J.P. Morgan Healthcare Conference December 16, 2025
  • Pharma Supply Chain & Security World Returns to London: Building a Connected and Resilient Ecosystem December 16, 2025
  • Annovis to Host Corporate Update Webinar on January 28, 2026 December 16, 2025
  • SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies December 16, 2025
PRIVACY POLICY
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn

©2025 Boston Biotech Clinical Research. All Rights Reserved.   |   Web Design by Nisse Designs